Nabil Ismaili, Director of Medical Oncology and Radiotherapy Department at Mohammed VI University of Sciences and Health, shared on LinkedIn:
“Therapeutic Innovations in Luminal and HER2-Positive Breast Cancers: A Roundtable of Excellence at the Université Mohammed VI des Sciences et de la Santé – UM6SS
Yesterday, as part of our continuing education program, the Medical Oncology and Radiotherapy departments of UM6SS Casablanca organized a round table dedicated to recent advances in the management of luminal and HER2-positive breast cancers.
A big thank you to our moderators and facilitators:
- Prof. Dr. Meriem Damou – Medical Oncology, HCK
- Prof. Mohammed Sqalli Houssaini HOUSSAINI – Medical Oncology, HCK
- Prof. Nabil ISMAILI – Director of Medical Oncology and Radiotherapy Specialty, UM6SS
With the active participation of:
- Prof. Sanaa El Majjaoui – Head of Radiotherapy, HCK
- Prof. zineb DAHBI – Radiotherapy, HCK
- Dr. Rita Bentahila – Radiation Therapy, HCK
The discussions focused on personalized therapeutic strategies, the integration of new targeted therapies and the optimization of treatment sequences, in a rich and constructive multidisciplinary dynamic.
Thank you to all the residents for their commitment and the quality of the discussions.
Thank you to Sothema Laboratories for their support.
Together, let’s make continuing education the engine of clinical excellence.”